https://doi.org/10.1186/s12885-018-4888-2
M
Michiko Imamura
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
57
Papers
883
Citations
20
h-index
29
i10-index
Michiko Imamura is an academic researcher. The author has contributed to research in topics: Breast Cancer Treatment Studies & Cancer Immunotherapy and Biomarkers & HER2/EGFR in Cancer Research. The author has an h-index of 20, co-authored 49 publications.
Papers by this author
worksPredictive impact of absolute lymphocyte counts for progression-free survival in human epidermal growth factor receptor 2-positive advanced breast cancer treated with pertuzumab and trastuzumab plus eribulin or nab-paclitaxel
2018 · BMC Cancer · 55 citations
Prognostic significance of preoperative 18F-FDG PET/CT for breast cancer subtypes
2016 · The Breast · 46 citations
https://doi.org/10.1016/j.breast.2016.08.003
Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers
2017 · Breast Cancer Research and Treatment · 36 citations
https://doi.org/10.1007/s10549-017-4575-z
Significance of baseline neutrophil-to-lymphocyte ratio for progression-free survival of patients with HER2-positive breast cancer treated with trastuzumab emtansine
2019 · Scientific Reports · 33 citations
https://doi.org/10.1038/s41598-018-37633-0
Prognostic significance of tumor-infiltrating lymphocytes may differ depending on Ki67 expression levels in estrogen receptor-positive/HER2-negative operated breast cancers
2019 · Breast Cancer · 33 citations
https://doi.org/10.1007/s12282-019-00977-0
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers
2013 · International Journal of Clinical Oncology · 18 citations
https://doi.org/10.1007/s10147-013-0585-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat